Glenmark concludes post marketing surveillance study on Favipiravir (FabiFlu) in COVID patients
India | Sep 15, 2021, 11:35 AM ISTOn June 19, 2020, Glenmark became the first company in India to receive restricted emergency use approval from India's drug regulator for Favipiravir (FabiFlu).